73764011000036108: Boostrix-IPV (trade product)
Status: current, Primitive. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Expanded Value Set
Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Boostrix-IPV injection suspension, 0.5 mL syringe |
Is a |
False |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection suspension, 0.5 mL syringe |
has TP |
False |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection suspension, 10 x 0.5 mL syringes |
has TP |
False |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection suspension, 10 x 0.5 mL syringes |
has TP |
False |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection suspension, 0.5 mL syringe |
has TP |
False |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection, 0.5 mL syringe |
has TP |
True |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection, 0.5 mL syringe |
Is a |
True |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection, 10 x 0.5 mL syringes |
has TP |
True |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV injection, 10 x 0.5 mL syringes |
has TP |
True |
Boostrix-IPV |
Inferred relationship |
Some |
|
Boostrix-IPV (Bordetella pertussis filamentous haemagglutinin antigen 8 microgram + Bordetella pertussis pertactin antigen 2.5 microgram + Bordetella pertussis toxoid 8 microgram + diphtheria toxoid 2 international units + poliovirus serotype 1 inactivated antigen 40 D antigen units + poliovirus serotype 2 inactivated antigen 8 D antigen units + poliovirus serotype 3 inactivated antigen 32 D antigen units + tetanus toxoid 20 international units) injection, 1 x 0.5 mL syringe (trade product pack) |
has TP |
True |
Boostrix-IPV |
Inferred relationship |
Some |
|
Reference Sets
Vaccine reference set
Trade product reference set
Back to Start